Nasal Steroid Spray for MS Relapses
Part of Brain & nervous system, Immune system & allergy clinical trials.
This study tests a nasal spray form of the steroid methylprednisolone for treating MS relapses. The goal is to see if this new way of taking the medicine works as well or better than standard treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 65 years old.
- You must have relapsing-remitting MS (RRMS) and have been diagnosed for at least 3 months but no more than 10 years.
- Your disability level should be mild to moderate (able to walk with or without a cane).
- You cannot have taken steroids (like prednisone) in the last 3 days.
- You must not have certain health issues like high blood pressure, diabetes, active infections, glaucoma, or a history of nasal problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study tests whether corticosteroid medicine can reduce inflammation at the edge of active multiple sclerosis (MS) plaques seen on MRI. It may help calm “hot” areas in the brain where MS activity is happening.
This study tests if using a nebulizer to deliver steroid spray can help people with chronic sinusitis (CRS) without prior sinus surgery. It focuses on improving symptoms like nasal congestion and facial pressure.
This study tests a nasal spray made from mastic gum oil, combined with a lower dose of a standard steroid nasal spray, to treat chronic sinusitis (long-lasting inflammation of the sinuses). It may help reduce symptoms with fewer side effects from steroids.
This trial tests a nasal spray called Foralumab for people with multiple system atrophy (MSA). The goal is to see if the spray can help reduce symptoms or slow the disease. It is for people who are otherwise healthy enough to safely participate.
This study tests if a combination of two nasal sprays (a decongestant and a steroid) can help people with chronic nasal blockage who haven't gotten relief from steroid sprays alone.
This trial compares two medications, hydrocortisone and methylprednisolone, to see which works better for people whose adrenal glands have stopped working properly after taking high doses of steroids (methylprednisolone) for more than 4 weeks.
Hear when a new Multiple Sclerosis, Relapsing-Remitting trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.